Influence of route of administration/drug formulation and other factors on adherence to treatment in rheumatoid arthritis (pain related) and dyslipidemia (non-pain related)-Reference-Cited by-同舟云学术

Influence of route of administration/drug formulation and other factors on adherence to treatment in rheumatoid arthritis (pain related) and dyslipidemia (non-pain related)

Published:2017-04-28 Issue:7 Volume:33 Page:1231-1246
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Fautrel Bruno¹,Balsa Alejandro²,Van Riel Piet³,Casillas Marta⁴,Capron Jean-Philippe⁵,Cueille Carine⁵,de la Torre Inmaculada⁴

Affiliation:

1. Pierre et Marie Curie University, Sorbonne Universités; and Rheumatology Department, Pitié Salpêtrière Hospital, Paris, France;

2. Rheumatology Department and Health Research Institute (Idipaz), Hospital Universitario de La Paz, Madrid, Spain;

3. Scientific Institute for Quality of Healthcare, Radboud University Medical Center, Nijmegen, and Department of Rheumatology, Bernhoven, Uden, The Netherlands;

4. Lilly SA, Alcobendas, Madrid, Spain;

5. Lilly France, Neuilly-sur-Seine, France

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2017.1313209

Reference80 articles.

1. Understanding the major risk factors in the beginning and the progression of rheumatoid arthritis: current scenario and future prospects

2. The widening mortality gap between rheumatoid arthritis patients and the general population

3. The mortality of rheumatoid arthritis

4. National Institute for Health and Care Excellence. Rheumatoid arthritis: the management of rheumatoid arthritis in adults. CG79, February 2009. Available at: https://www.nice.org.uk/guidance/cg79 [Last accessed 19 March 2015]

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis;Rheumatology and Therapy;2022-10-13

2. Usage and Adherence of Seven Advanced Therapies with Differing Mechanisms of Action for Inflammatory Arthritis in Canada;Rheumatology and Therapy;2022-09-01

3. Practices among General Practitioners in Rheumatoid Arthritis (GEPRA-I): results of a region-wide online survey;BMC Primary Care;2022-06-03

4. Potential Benefits of the Self-Administration of Subcutaneous Methotrexate with Autoinjector Devices for Patients: A Review;Drug, Healthcare and Patient Safety;2021-03

5. Adherence to Treatment in Patients with Rheumatoid Arthritis from Spain;Patient Preference and Adherence;2021-01